LORANGER STEVEN R
SEC CIK 1226924 · EDGAR
BoughtSold
Most active insiders at EW, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| 2 | Zovighian Bernard J | CEO, Dir | — | $7.00M |
| 3 | Ullem Scott B. | CFO, CVP | — | $3.87M |
| 4 | Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| 5 | Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| 6 | Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| 7 | Bruls Annette | CVP, EMEACLA | — | $237.9K |
| 8 | STONE HEISZ LESLIE | Dir | — | $218.1K |
| 9 | Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| 10 | Davis Leslie C. | Dir | — | — |
| 16 | LORANGER STEVEN R | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-08 21:18 | 2026-05-08 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +4,315 | 8,997 | +92% | $0 |
| M | 2025-05-09 | 2025-05-09 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +4,682 | 63.9K | +8% | $0 |
| D | 2025-02-14 | 2025-02-14 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | M - OptEx | $45.32 | +5,739 | 66.1K | +10% | +$260.1K |
| D | 2025-02-14 | 2025-02-14 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | S - Sale+OE | $76.42 | -5,739 | 60.4K | -9% | -$438.6K |
| M | 2024-05-09 | 2024-05-08 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +4,054 | 59.4K | +7% | $0 |
| 2023-05-22 | 2023-05-18 | XYL | Xylem Inc. | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +1,580 | 13.8K | +13% | $0 | |
| M | 2023-05-15 | 2023-05-12 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +3,701 | 56.3K | +7% | $0 |
| 2022-05-16 | 2022-05-12 | XYL | Xylem Inc. | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +1,812 | 12.2K | +17% | $0 | |
| M | 2022-05-05 | 2022-05-04 | EW | Edwards Lifesciences | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +3,037 | 52.6K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations